The store will not work correctly when cookies are disabled.
rac-1,3-Dioxo-2-(1,3,6-trimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)-2,3-dihydro-1H-benzo[de]isoquinoline-5-carbonitrile
ID: ALA4099171
PubChem CID: 130471777
Max Phase: Preclinical
Molecular Formula: C23H16N4O3
Molecular Weight: 396.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc2c(cc1N1C(=O)c3cccc4cc(C#N)cc(c34)C1=O)n(C)c(=O)n2C
Standard InChI: InChI=1S/C23H16N4O3/c1-12-7-18-19(26(3)23(30)25(18)2)10-17(12)27-21(28)15-6-4-5-14-8-13(11-24)9-16(20(14)15)22(27)29/h4-10H,1-3H3
Standard InChI Key: KZNDNGJCFUTVMP-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
23.4512 -18.0305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8798 -18.0269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1637 -17.6173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4500 -18.8587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7365 -19.2716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7372 -20.0977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4574 -20.5091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1655 -19.2720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1656 -20.0906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8707 -20.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5803 -20.0905 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5802 -19.2718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8706 -18.8603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2915 -20.5038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2891 -21.3307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0029 -21.7444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0036 -20.0923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7180 -20.5023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7226 -21.3320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5132 -21.5842 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9973 -20.9101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5057 -20.2416 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.2958 -18.8596 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.8697 -21.3235 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.7565 -19.4548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7727 -22.3682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8231 -20.9055 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.5730 -21.7420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0246 -20.5123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3105 -20.9272 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 4 2 0
13 2 1 0
2 3 2 0
3 1 1 0
8 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 9 2 0
8 9 1 0
8 13 2 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
14 15 2 0
15 16 1 0
16 19 2 0
18 17 2 0
17 14 1 0
11 14 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
12 23 2 0
10 24 2 0
22 25 1 0
20 26 1 0
21 27 2 0
15 28 1 0
29 30 3 0
6 29 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 396.41 | Molecular Weight (Monoisotopic): 396.1222 | AlogP: 3.01 | #Rotatable Bonds: 1 |
Polar Surface Area: 88.10 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.20 | CX LogD: 3.20 |
Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.46 | Np Likeness Score: -1.09 |
References
1. Bouché L, Christ CD, Siegel S, Fernández-Montalván AE, Holton SJ, Fedorov O, Ter Laak A, Sugawara T, Stöckigt D, Tallant C, Bennett J, Monteiro O, Díaz-Sáez L, Siejka P, Meier J, Pütter V, Weiske J, Müller S, Huber KVM, Hartung IV, Haendler B.. (2017) Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains., 60 (9): [PMID:28402630] [10.1021/acs.jmedchem.7b00306] |